Skip to main content
Earnings Labs
Zentalis Pharmaceuticals, Inc. logo

Zentalis Pharmaceuticals, Inc. (ZNTL)

NASDAQ·Healthcare·Biotechnology

$3.51

-2.09%

Mkt Cap $249.86M

Analyst Ratings

Buy

2

Hold

0

Sell

0

Price Target (15 analysts)

$8.33

Range $5.00$10.00

Implied Upside

+137.3%

Consensus $8.33 vs current $3.51